, Volume 170, Issue 4, pp 423–428 | Cite as

The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia

A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks
  • A. RodenbeckEmail author
  • S. Cohrs
  • W. Jordan
  • G. Huether
  • E. Rüther
  • G. Hajak
Original Investigation



In primary care, sedating antidepressants are often used for treating insomnia, although their underlying sleep-promoting mechanisms are only incompletely understood. Since enhanced evening and nocturnal plasma cortisol levels are supposed to maintain insomniac sleep complaints, a functional link between sleep and cortisol secretion in the mode of action of antidepressants in insomnia might be suspected.


We therefore investigated the effects of the tricyclic antidepressant doxepin on nocturnal sleep and plasma cortisol concentration in ten patients (age 41.3±9.5 years) with chronic primary insomnia between 1700 hours and 0800 hours.


Single infusions of placebo and 25 mg doxepin were applied following a double-blind, randomized cross-over design. Afterward, all patients received 25 mg doxepin p.o. for 3 weeks in an open-study design.


Both doxepin application forms improved sleep significantly and reduced mean cortisol levels from 9.0±1.7 µg/l (single placebo i.v.) to 7.5±1.6 µg/l (single doxepin i.v.) or 7.6±2.0 µg/l (subchronic doxepin p.o.). The duration of the quiescent period of the cortisol rhythm was significantly prolonged following both doxepin administrations compared with placebo.


The results implicate that the sleep-improving effects of doxepin are mediated at least in part by a normalization of hypothalamic–pituitary–adrenal axis functions. Although in some patients rebound insomnia and specific side effects must be considered, our findings give a further rationale for the use of antidepressants in the treatment of primary insomnia.


Insomnia Antidepressant Cortisol Sedative 


  1. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DCGoogle Scholar
  2. American Sleep Disorders Association (1990) The international classification of sleep disorders. American Sleep Disorders Association, Rochester, MNGoogle Scholar
  3. Attenburrow MJ, Mitter PR, Whale R, Terao T, Cowen PJ (2001) Low-dose citalopram as a 5-HT neuroendocrine probe. Psychopharmacology 155:323–326PubMedGoogle Scholar
  4. Balter MB, Uhlenhuth EH (1992) New epidemiologic findings about insomnia and its treatment. J Clin Psychiatry 53:34–39PubMedGoogle Scholar
  5. Bhagwagar Z, Hafizi S, Cowen PJ (2002a) Acute citalopram administration produces correlated increases in plasma and salivary cortisol. Psychopharmacology 163:118–120Google Scholar
  6. Bhagwagar Z, Whale R, Cowen PJ (2002b) State and trait abnormalities in serotonin function in major depression. Br J Psychiatry 180:24–28PubMedGoogle Scholar
  7. Berlin I, Warot D, Legout V, Guilleminault S, Schollnhammer G, Puech AJ (1998) Blunted 5-HT1A-receptor agonist-induced corticotropin and cortisol responses after long-term ipsapirone and fluoxetine administration to healthy subjects. Clin Pharmacol Ther 63:428–436Google Scholar
  8. Bixler EO, Vgontzas AN, Lin HM, Vela-Bueno A, Kales A (2002) Insomnia in central Pennsylvania. J Psychosom Res 53:589–592CrossRefPubMedGoogle Scholar
  9. Duncan WCJ (1996) Circadian rhythms and the pharmacology of affective disorders. Pharmacol Ther 71:253–312CrossRefPubMedGoogle Scholar
  10. Feuillade P, Pringuey D, Belugou JL, Robert P, Darcourt G (1992) Trimipramine: acute and lasting effects on sleep in healthy and major depressive subjects. J Affect Disord 24:135–145PubMedGoogle Scholar
  11. Golden RN, Hsiao J, Lane E, Hicks R, Rogers S, Potter EZ (1989) The effect of intravenous clomipramine on neurohormones in normal subjects. J Clin Endocrinol Metab 68:632–637PubMedGoogle Scholar
  12. Götze U, Tölle R (1988) Circadian rhythm of free urinary cortisol, temperature and heart rate in endogenous depression and under antidepressant therapy. Neuropsychobiology 18:175–184Google Scholar
  13. Hajak G, Rodenbeck A, Adler L, Huether G, Bandelow B, Herrendorf G, Staedt J, Rüther E (1996) Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomnia. Pharmacopsychiatry 29:187–192PubMedGoogle Scholar
  14. Hajak G, Rodenbeck A, Ehrenthal HD, Leonard S, Wedekind D, Sengos G, Zhou D, Huether G (1997) No evidence for a physiological coupling between melatonin and glucocorticoids. Psychopharmacology 133:313–322CrossRefPubMedGoogle Scholar
  15. Hajak G, Rodenbeck A, Voderholzer U, Riemann D, Cohrs S, Hohagen F, Berger M, Rüther E (2001a) Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry 62:453–463PubMedGoogle Scholar
  16. Hajak G on behalf of the SINE study group (2001b) Epidemiology of severe insomnia and its consequences in Germany. Eur Arch Psychiatry Clin Neurosci 251:49–56CrossRefPubMedGoogle Scholar
  17. Harmer CJ, Bhagwagar Z, Shelley N, Cowen PJ (2003) Contrasting effects of citalopram and reboxetine on waking salivary cortisol. Psychopharmacology 167:112–114PubMedGoogle Scholar
  18. Hohagen F, Montero RF, Weiss E, Lis S, Schönbrunn E, Dressing H, Riemann D, Berger M (1994) Treatment of primary insomnia with trimipramine: an alternative to benzodiazepine hypnotics? Eur Arch Psychiatry Clin Neurosci 244:65–72PubMedGoogle Scholar
  19. Holl WR, Fehm HL, Voigt KH, Steiner K, Teller W (1986) Acute effects of desipramine and clomipramine on pituitary-adrenal axis in man. Horm Metab Res 18:134–137PubMedGoogle Scholar
  20. Inder WJ, Prickett TCR, Mulder RT, Donald RA, Joyce PR (2001) Reduction of basal afternoon plasma ACTH during early treatment of depression with fluoxetine. Psychopharmacology 156:73–78Google Scholar
  21. Jarrett DB, Miewals JM, Kupfer DJ (1988) Acute changes in sleep-related hormone secretion of depressed patients following oral imipramine. Biol Psychiatry 24:541–554Google Scholar
  22. Jarrett DB, Pollock B, Miewald JM, Kupfer DJ (1991) Acute effect of intravenous clomipramine upon sleep-related hormone secretion in depressed outpatients and healthy subjects. Biol Psychiatry 29:3–14Google Scholar
  23. Kapitany T, Schindl M, Schindler SD, Hesselmann B, Fureder T, Barnas C, Sieghart W, Kasper S (1999) The citalopram challenge test in patients with major depression and in healthy controls. Psychiatry Res 88:75–88PubMedGoogle Scholar
  24. Laakmann G, Wittmann M, Gugath M, Mueller OA, Treusch J, Wahlster U, Stalla GK (1984) Effects of psychotropic drugs (desimipramine, chlorimipramine, sulpiride and diazepam) on the human HPA axis. Psychopharmacology 84:66–70PubMedGoogle Scholar
  25. Laakmann G, Schoen HW, Blaschke D, Wittmann M (1985) Dose-dependent growth hormone, prolactin and cortisol stimulation after i.v. administration of desimipramine in human subjects. Psychoneuroendocrinology 10:83–93CrossRefPubMedGoogle Scholar
  26. Laakmann G, Schule C, Baghai T, Waldvogel E (1999) Effects of mirtazapine on growth hormone, prolactin, and cortisol secretion in healthy male subjects. Psychoneuroendocrinology 24:769–784CrossRefPubMedGoogle Scholar
  27. Linkowski P, Mendlewicz J, Kerkhofs M, Leclercq R, Goldstein J, Brasseur M, Copinschi G, van Cauter E (1987) 24-hour profiles of adrenocroticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocr Metab 64:141–152Google Scholar
  28. Lisansky J, Fava GA, Zielezny MA, Morphy MA, Kellner R (1987) Nocturnal prolactin and cortisol secretion and recovery from melancholia. Psychoneuroendocrinology 12:303–311CrossRefPubMedGoogle Scholar
  29. Madjirova NP, Tashev TG, Delchev NN, Bakalova RG (1995) Interrelationship between cortisol levels in plasma and the circadian rhythm of temperature, pulse and blood pressure in depressed patients with good and disturbed sleep. Int J Psychophysiol 20:145–154CrossRefPubMedGoogle Scholar
  30. Monteleone P (1991) Effects of trazodone on plasma cortisol in normal subjects. A study with drug plasma levels. Neuropsychopharmacology 5:61–64PubMedGoogle Scholar
  31. Nowell PD, Reynolds CF, Buysse DJ, Dew MA, Kupfer DJ (1999) Paroxetine in the treatment of primary insomnia: preliminary clinical and electroencephalogram sleep data. J Clin Psychiatry 60:89–95Google Scholar
  32. Ohayon MM, Caulet M, Piest RG, Guilleminault C (1998) Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 51:273–283Google Scholar
  33. Piacentini MF, Meeusen R, Buyse L, De-Schutter G, Kempenaers F, Van-Nijvel J, De-Meirleir K (2002) No effect of a noradrenergic reuptake inhibitor on performance in trained cyclists. Med Sci Sports Exerc 34:1189–1193PubMedGoogle Scholar
  34. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. U.S. Government Printing Office, WashingtonGoogle Scholar
  35. Riemann D, Voderholzer U, Cohrs S, Rodenbeck A, Hajak G, Rüther E, Wiegand MH, Laakmann G, Baghai T, Fischer W, Hoffmann M, Hohagen F, Mayer G, Berger M (2002) Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study. Pharmacopsychiatry 35:165–174CrossRefPubMedGoogle Scholar
  36. Rodenbeck A, Hajak G (2001) Neuroendocrine dysregulation in primary insomnia. Rev Neurol (Paris) 157:s57–s61Google Scholar
  37. Rodenbeck A, Huether G, Rüther E, Hajak G (2002) Interactions between evening and nocturnal cortisol secretion and sleep parameters in patients with severe chronic primary insomnia. Neurosci Lett 324:159–163CrossRefPubMedGoogle Scholar
  38. Schlosser R, Wetzel H, Dorr H, Rossbach W, Hiemke C, Benkert O (2000) Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers. Psychoneuroendocrinology 25:377–388CrossRefPubMedGoogle Scholar
  39. Seifritz E, Baumann P, Müller MJ, Annen O, Amey M, Hemmeter U, Hatzinger M, Chardon F, Holsboer-Trachsler E (1996) Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe. Neuropsychopharmacology 14:253–263Google Scholar
  40. Simen S, Rodenbeck A, Schlaf G, Müller-Popkes K, Hajak G (1996) Sleep complaints and hypnotic use by the elderly—results of a representative survey in West Germany. Wien Med Wochenschr 146:306–309PubMedGoogle Scholar
  41. Simon GE, VonKorff M (1997) Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry 154:1417–1423PubMedGoogle Scholar
  42. Sonntag A, Rother B, Guldner J, Yassouridis A, Holsboer F, Steiger A (1996) Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression. Depression 4:1–13CrossRefPubMedGoogle Scholar
  43. Staner L, Kerkhofs M, Detroux D, Leyman S, Linkowski P, Mendlewicz J (1995) Acute, subchronic and withdrawal sleep EEG changes during treatment with paroxetine and amitriptyline: a double-blind randomized trial in major depression. Sleep 18:470–477PubMedGoogle Scholar
  44. Steiger A, von Bardeleben U, Herth T, Holsboer F (1989) Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before and after recovery. J Affect Disord 16:189–195CrossRefPubMedGoogle Scholar
  45. Steiger A, von Bardeleben U, Guldner J, Lauer C, Rother B, Holsboer F (1993) The sleep EEG and nocturnal hormonal secretion studies on changes during the course of depression and on effects of CNS-active drugs. Prog Neuropsychopharmacol Biol Psychiatry 17:125–137Google Scholar
  46. Torpy DJ, Grice JE, Hockings GI, Crosbie GV, Walters MM, Jackson RV (1995) The effect of desipramine on basal and naloxone-stimulated cortisol secretion in human: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion. J Clin Endocr Metab 80:802–806PubMedGoogle Scholar
  47. Van Cauter E, Leproult R, Kupfer DJ (1996) Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 81:2468–2473Google Scholar
  48. Vgontzas AN, Tsigos C, Bixler EO, Stratakis CA, Zachman K, Kales A, Vela-Bueno A, Chrousos GP (1998) Chronic insomnia and activity of the stress system: a preliminary study. J Psychosom Res 45:21–31CrossRefPubMedGoogle Scholar
  49. Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A, Kales A, Chrousos GP (2001) Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab 86:3787–3794Google Scholar
  50. Walsh AE, Hockney RA, Campling G, Cowen PJ (1993) Neuroendocrine and temperature effects of nefazodone in healthy volunteers. Biol Psychiatry 33:115–119Google Scholar
  51. Walsh JK, Schweitzer PK (1999) Ten-year trends in the pharmacological treatment of insomnia. Am J Psychiatry 22:371–375Google Scholar
  52. Wiegand M, Berger M (1989) Action of trimipramine on sleep and pituitary hormone secretion. Drugs 38[Suppl 1]:35–50Google Scholar
  53. Wilkins JN, Spar JE, Carlson HE (1989) Desipramine increases circulating growth hormone in elderly patients: a pilot study. Psychoneuroendocrinology 14:195–202CrossRefPubMedGoogle Scholar
  54. Wittchen HU, Krause P, Hofler M, Pittrow D, Winter S, Spiegel B, Hajak G, Riemann D, Steiger A, Pfister H (2001) NISAS-2000. The nationwide insomnia screening and awareness study. Prevalence and interventions in primary care. Fortschr Med Orig 119:9–19PubMedGoogle Scholar
  55. World Health Organization (1991) Mental and behavioural disorders (including disorders of psychological development). Clinical descriptions and guidelines. In: International classification of diseases, 10th revn. World Health Organization, GenevaGoogle Scholar
  56. Wysowski DK, Baum C (1991) Outpatient use of prescription sedative-hypnotic drugs in the United States, 1970 through 1989. Arch Intern Med 151:1779–1783CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • A. Rodenbeck
    • 1
    Email author
  • S. Cohrs
    • 1
  • W. Jordan
    • 1
  • G. Huether
    • 1
  • E. Rüther
    • 1
  • G. Hajak
    • 1
    • 2
  1. 1.Department of Psychiatry and PsychotherapyUniversity of GöttingenGöttingenGermany
  2. 2.Department of Psychiatry and PsychotherapyUniversity of RegensburgRegensburgGermany

Personalised recommendations